Cardiac Resynchronisation Therapy in Patients with Moderate to Severe Heart Failure in Germany: A Cost-Utility Analysis of the Additional Defibrillator

被引：0
|
作者：
Moritz Hadwiger
Fabian-Simon Frielitz
Nora Eisemann
Christian Elsner
Nikolaos Dagres
Gerhard Hindricks
Alexander Katalinic
机构：
[1] University of Lübeck,Institute of Social Medicine and Epidemiology
[2] University of Leipzig,Heart Center Leipzig
来源：
Applied Health Economics and Health Policy | 2021年 / 19卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：57 / 68
页数：11
相关论文
共 50 条
  • [1] Cardiac Resynchronisation Therapy in Patients with Moderate to Severe Heart Failure in Germany: A Cost-Utility Analysis of the Additional Defibrillator
    Hadwiger, Moritz
    Frielitz, Fabian-Simon
    Eisemann, Nora
    Elsner, Christian
    Dagres, Nikolaos
    Hindricks, Gerhard
    Katalinic, Alexander
    [J]. APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2021, 19 (01) : 57 - 68
  • [2] COST-EFFECTIVENESS OF CARDIAC RESYNCHRONISATION THERAPY FOR PATIENTS WITH MODERATE-TO-SEVERE HEART FAILURE
    Neyt, M.
    Stroobandt, S.
    Obyn, C.
    Camberlin, C.
    Devriese, S.
    De Laet, C.
    Van Brabandt, H.
    [J]. VALUE IN HEALTH, 2011, 14 (07) : A253 - A253
  • [3] The effect of cardiac resynchronisation therapy on cognitive function in patients with moderate to severe heart failure
    Freeman, C. I.
    McCarthy, R. A.
    Fletcher, L.
    Smith, L. A.
    Kelly, D.
    Cowburn, P. J.
    [J]. EUROPEAN HEART JOURNAL, 2015, 36 : 389 - 389
  • [4] Cost-effectiveness of cardiac resynchronisation therapy for patients with moderate-to-severe heart failure: a lifetime Markov model
    Neyt, Mattias
    Stroobandt, Serge
    Obyn, Caroline
    Camberlin, Cecile
    Devriese, Stephan
    De Laet, Chris
    Van Brabandt, Hans
    [J]. BMJ OPEN, 2011, 1 (02):
  • [5] Cardiac resynchronisation therapy with or without defibrillator in patients with heart failure - An analysis from the Swedish Heart Failure Registry
    Schrage, B. Benedikt
    Lund, L. H.
    Melin, M.
    Benson, L.
    Uijl, A.
    Dahlstroem, U.
    Braunschweig, F.
    Line, C.
    Savarese, G.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 : 10 - 11
  • [6] Cost-effectiveness of cardiac resynchronisation therapy in heart failure patients
    Mascioli, G
    Curnis, A
    Bontempi, L
    Bordonali, T
    Dei Cas, L
    [J]. Emerging Pathologies in Cardiology, 2005, : 215 - 219
  • [7] An early analysis of cost-utility of baroreflex activation therapy in advanced chronic heart failure in Germany
    Oleg Borisenko
    Jochen Müller-Ehmsen
    JoAnn Lindenfeld
    Erik Rafflenbeul
    Christian Hamm
    [J]. BMC Cardiovascular Disorders, 18
  • [8] An early analysis of cost-utility of baroreflex activation therapy in advanced chronic heart failure in Germany
    Borisenko, Oleg
    Mueller-Ehmsen, Jochen
    Lindenfeld, JoAnn
    Rafflenbeul, Erik
    Hamm, Christian
    [J]. BMC CARDIOVASCULAR DISORDERS, 2018, 18
  • [9] COST-UTILITY ANALYSIS OF DAPAGLIFLOZIN IN PATIENTS WITH HEART FAILURE IN PANAMA
    Ordonez, J.
    Gonzales, L.
    Romero, A.
    Effio, J.
    Ordonez, A.
    Hidalgo Godinez, J.
    Villalobos, K.
    [J]. VALUE IN HEALTH, 2022, 25 (07) : S403 - S403
  • [10] Heartbeat: cardiac resynchronisation therapy pacemaker or defibrillator in patients with heart failure with reduced ejection fraction?
    Otto, Catherine M.
    [J]. HEART, 2022, 108 (15) : 1161 - 1163
12345